-
Anastas JN, Zee BM, Kalin JH, Kim M, Guo R, Alexandrescu S, Blanco MA, Giera S, Gillespie SM, Das J, Wu M, Nocco S, Bonal DM, Nguyen QD, Suva ML, Bernstein BE, Alani R, Golub TR, Cole PA, Filbin MG, Shi Y. Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG. Cancer Cell. 2019 11 11; 36(5):528-544.e10. PMID: 31631026
-
Kim E, Zucconi BE, Wu M, Nocco SE, Meyers DJ, McGee JS, Venkatesh S, Cohen DL, Gonzalez EC, Ryu B, Cole PA, Alani RM. MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma. Cancer Res. 2019 05 15; 79(10):2649-2661.View Related Profiles. PMID: 30910803; PMCID: PMC6522293; DOI: 10.1158/0008-5472.CAN-18-2331;
-
Eisenstein A, Gonzalez EC, Raghunathan R, Xu X, Wu M, McLean EO, McGee J, Ryu B, Alani RM. Emerging Biomarkers in Cutaneous Melanoma. Mol Diagn Ther. 2018 04; 22(2):203-218.View Related Profiles. PMID: 29411301
-
Eisenstein A, Panova IP, Chung HJ, Goldberg LJ, Zhang Q, Lazova R, Bhawan J, Busam KJ, Symanowski JT, Alani RM, Ryu B. Quantitative assessment of neuropilin-2 as a simple and sensitive diagnostic assay for spitzoid melanocytic lesions. Melanoma Res. 2018 Feb; 28(1):71-75.View Related Profiles. PMID: 29227334; PMCID: PMC5805139; DOI: 10.1097/CMR.0000000000000416;
-
Kalin JH, Wu M, Gomez AV, Song Y, Das J, Hayward D, Adejola N, Wu M, Panova I, Chung HJ, Kim E, Roberts HJ, Roberts JM, Prusevich P, Jeliazkov JR, Roy Burman SS, Fairall L, Milano C, Eroglu A, Proby CM, Dinkova-Kostova AT, Hancock WW, Gray JJ, Bradner JE, Valente S, Mai A, Anders NM, Rudek MA, Hu Y, Ryu B, Schwabe JWR, Mattevi A, Alani RM, Cole PA. Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors. Nat Commun. 2018 01 04; 9(1):53.View Related Profiles. PMID: 29302039; PMCID: PMC5754352; DOI: 10.1038/s41467-017-02242-4;
-
Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Melanoma Manag. 2017 Mar; 4(1):13-37.View Related Profiles. PMID: 28758010; PMCID: PMC5480135; DOI: 10.2217/mmt-2016-0022;
-
-
-
-
-
-
Alani RM, Cole PA, Yan G, Bowers EM. USE OF HISTONE ACETYLTRANSFERASE INHIBITORS AS NOVEL ANTI-CANCER THERAPIES. 2015.
-
Rossi M, Tuck J, Kim OJ, Panova I, Symanowski JT, Mahalingam M, Riker AI, Alani RM, Ryu B. Neuropilin-2 gene expression correlates with malignant progression in cutaneous melanoma. Br J Dermatol. 2014 Aug; 171(2):403-8.View Related Profiles. PMID: 24359286; DOI: 10.1111/bjd.12801;
-
Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong SM, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih lM, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang TL, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014 Feb 19; 6(224):224ra24. PMID: 24553385; PMCID: PMC4017867; DOI: 10.1126/scitranslmed.3007094;
-
Laura Blaha, Chentian Zhang, Rhoda Alani, Mario Cabodi, and Joyce Wong. Biomedical Engineering Society, 2014 Annual Meeting. A Microfluidic Platform to Evaluate the Role of Vessel Permeability in Tumor Cell Extravasation. San Antonio. 2014.
-
Jay H. Kalin, Muzhou Wu, Dawn Hayward, Liqing Wang, Justin M. Roberts, Polina Prusevich, Wayne W. Hancock, James E. Bradner, Byungwoo Ryu, Rhoda M. Alani, Philip A. Cole. American Society of Biochemistry and Molecular Biology Annual Meeting. CoREST in Peace: Dual Action Inhibitors of Histone Deacetylase and LSD1 Demethylase. 2014.
-
Cao J, Wan L, Hacker E, Dai X, Lenna S, Jimenez-Cervantes C, Wang Y, Leslie NR, Xu GX, Widlund HR, Ryu B, Alani RM, Dutton-Regester K, Goding CR, Hayward NK, Wei W, Cui R. MC1R is a potent regulator of PTEN after UV exposure in melanocytes. Mol Cell. 2013 Aug 22; 51(4):409-22.View Related Profiles. PMID: 23973372; PMCID: PMC3792490; DOI: 10.1016/j.molcel.2013.08.010;
-
Howard JD, Moriarty WF, Park J, Riedy K, Panova IP, Chung CH, Suh KY, Levchenko A, Alani RM. Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration. Pigment Cell Melanoma Res. 2013 Sep; 26(5):697-707. PMID: 23773728; DOI: 10.1111/pcmr.12131;
-
-
Yan G, Eller MS, Elm C, Larocca CA, Ryu B, Panova IP, Dancy BM, Bowers EM, Meyers D, Lareau L, Cole PA, Taverna SD, Alani RM. Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells. J Invest Dermatol. 2013 Oct; 133(10):2444-52.View Related Profiles. PMID: 23698071; PMCID: PMC4380234; DOI: 10.1038/jid.2013.187;
-
Alani RM, Byungwoo R. BIOMARKERS FOR MELANOMA. 2012.
-
Alberg AJ, Jorgensen TJ, Ruczinski I, Wheless L, Shugart YY, Berthier-Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Francis L, Alani RM, Smith MW, Strickland PT. DNA repair gene variants in relation to overall cancer risk: a population-based study. Carcinogenesis. 2013 Jan; 34(1):86-92. PMID: 23027618; PMCID: PMC3534189; DOI: 10.1093/carcin/bgs304;
-
Jorgensen TJ, Ruczinski I, Yao Shugart Y, Wheless L, Berthier Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer. Cancer Epidemiol. 2012 Oct; 36(5):e288-93. PMID: 22677152; PMCID: PMC3438291; DOI: 10.1016/j.canep.2012.05.001;
-
Ruczinski I, Jorgensen TJ, Shugart YY, Schaad YB, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Wheless L, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ. A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype. Carcinogenesis. 2012 Sep; 33(9):1692-8. PMID: 22581838; PMCID: PMC3514896; DOI: 10.1093/carcin/bgs170;
-
Wheless L, Kistner-Griffin E, Jorgensen TJ, Ruczinski I, Berthier-Schaad Y, Kessing B, Hoffman-Bolton J, Francis L, Shugart YY, Strickland PT, Kao WH, Alani RM, Smith MW, Alberg AJ. A community-based study of nucleotide excision repair polymorphisms in relation to the risk of non-melanoma skin cancer. J Invest Dermatol. 2012 May; 132(5):1354-62. PMID: 22336945; PMCID: PMC3326207; DOI: 10.1038/jid.2012.4;
-
Rushing EC, Stine MJ, Hahn SJ, Shea S, Eller MS, Naif A, Khanna S, Westra WH, Jungbluth AA, Busam KJ, Mahalingam M, Alani RM. Neuropilin-2: a novel biomarker for malignant melanoma? Hum Pathol. 2012 Mar; 43(3):381-9.View Related Profiles. PMID: 21840568; PMCID: PMC3246122; DOI: 10.1016/j.humpath.2011.05.008;
-
Clipp SL, Burke A, Hoffman-Bolton J, Alani R, Liégeois NJ, Alberg AJ. Sun-seeking behavior to increase cutaneous vitamin D synthesis: when prevention messages conflict. Public Health Rep. 2011 Jul-Aug; 126(4):533-9. PMID: 21800747; PMCID: PMC3115212; DOI: 10.1177/003335491112600409;
-
Crump NT, Hazzalin CA, Bowers EM, Alani RM, Cole PA, Mahadevan LC. Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP. Proc Natl Acad Sci U S A. 2011 May 10; 108(19):7814-9. PMID: 21518915; PMCID: PMC3093510; DOI: 10.1073/pnas.1100099108;
-
Zigler M, Villares GJ, Dobroff AS, Wang H, Huang L, Braeuer RR, Kamiya T, Melnikova VO, Song R, Friedman R, Alani RM, Bar-Eli M. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Res. 2011 May 15; 71(10):3494-504. PMID: 21467165; PMCID: PMC3096710; DOI: 10.1158/0008-5472.CAN-10-3555;
-
Ryu B, Moriarty WF, Stine MJ, DeLuca A, Kim DS, Meeker AK, Grills LD, Switzer RA, Eller MS, Alani RM. Global analysis of BRAFV600E target genes in human melanocytes identifies matrix metalloproteinase-1 as a critical mediator of melanoma growth. J Invest Dermatol. 2011 Jul; 131(7):1579-83.View Related Profiles. PMID: 21451543; PMCID: PMC3116059; DOI: 10.1038/jid.2011.65;
-
-
Bowers EM, Yan G, Mukherjee C, Orry A, Wang L, Holbert MA, Crump NT, Hazzalin CA, Liszczak G, Yuan H, Larocca C, Saldanha SA, Abagyan R, Sun Y, Meyers DJ, Marmorstein R, Mahadevan LC, Alani RM, Cole PA. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol. 2010 May 28; 17(5):471-82. PMID: 20534345; PMCID: PMC2884008; DOI: 10.1016/j.chembiol.2010.03.006;
-
-
Kessides MC, Wheless L, Hoffman-Bolton J, Clipp S, Alani RM, Alberg AJ. Cigarette smoking and malignant melanoma: a case-control study. J Am Acad Dermatol. 2011 Jan; 64(1):84-90. PMID: 20334951; PMCID: PMC2924442; DOI: 10.1016/j.jaad.2010.01.041;
-
Silverthorn CF, Alani RM. Glyceraldehyde-3-phosphate dehydrogenase expression is altered by hypoxia in melanoma cells and primary human melanocytes. Melanoma Res. 2010 Feb; 20(1):61-3. PMID: 20051782; DOI: 10.1097/CMR.0b013e328333d8c2;
-
Wheless L, Ruczinski I, Alani RM, Clipp S, Hoffman-Bolton J, Jorgensen TJ, Liégeois NJ, Strickland PT, Alberg AJ. The association between skin characteristics and skin cancer prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2613-9. PMID: 19755654; PMCID: PMC2759861; DOI: 10.1158/1055-9965.EPI-09-0383;
-
Erin Michele Bowers, Gai Yan, Chandrani Mukherjee, Ling Wang, Cecilia Larocca, David J. Meyers, Andrew Orry, Rhoda M. Alani and Philip A. Cole. The FASEB Journal. Identification and characterization of a novel p300 HAT inhibitor. 2009.
-
Pirtini Cetingul, M., Herman, C., Alani, R. M. Proceedings ASME 2009 Summer Heat Transfer Conference. Skin imaging with infrared thermography and confocal microscopy. 2009.
-
Pirtini Cetingul, M., Herman, C., Alani, R. M. Proceedings ASME 2009 Summer Heat Transfer Conference. Skin imaging with infrared thermography and confocal microscopy. 2009.
-
EC Rushing, MJ Keefe, S Khanna, AA Jungbluth, KJ Busam, RM Alani. United States and Canadian Academy of Pathology. Neuropilin-2 Expression in Normal Tissues, Various Tumors, and Primary and Metastatic Melanomas. 2009.
-
Jason D. Howard, Whei Moriarty, Megan Stine and Rhoda M. Alani. Society for Melanoma Research International Melanoma Congress. A Functional Evaluation of Notch Signaling in the Context of Melanoma-Endothelial Cell Communication and Tumor Progression. Boston. 2009.
-
Whei F. Moriarty, Megan J. Stine, C. Joanne Wang, Byungwoo Ryu, Andre Levchenko, and Rhoda M. Alani. Society for Melanoma Research International Melanoma Congress. Integration of Genotypic and Phenotypic Screenings Reveal Molecular Mediators of Melanoma-Stromal Interaction. Boston. 2009.
-
Gai Yan, Erin Bowers, Cecilia Larocca, Lisa Lareau, Beverley Dancy, David Meyers, Philip A. Cole, and Rhoda M. Alani. Society for Melanoma Research International Melanoma Congress. Functional Significance of a Small Molecule Inhibitor of P300/CBP Histone Acetyltransferase Activity in Melanoma. Boston. 2009.
-
Gai Yan, Cecilia Larocca, Erin Bowers, Beverley Dancy, David Meyers, Philip A. Cole., and Rhoda M. Alani. Epigenetics in Cancer Therapy. Inhibitors of Histone Acetyltransferases as Novel Cancer Therapies. 2009.
-
Kessides MC; Wheless L; Hoffman-Bolton J; Clipp S; Alani RM and Alberg AJ. American Federation for Medical Research-Eastern Regional Meeting. Cigarette Smoking and Malignant Melanoma-A Case-Control Study. Washington DC. 2009.
-
-
-
Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, Alani R, Liégeois NJ, Hoffman SC, Hoffman-Bolton J, Strickland PT, Helzlsouer KJ, Alberg AJ. Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst. 2008 Sep 3; 100(17):1215-22. PMID: 18728282; PMCID: PMC2720713; DOI: 10.1093/jnci/djn260;
-
DeLuca AM, Srinivas A, Alani RM. BRAF kinase in melanoma development and progression. Expert Rev Mol Med. 2008; 10:e6. PMID: 18279546; DOI: 10.1017/S1462399408000604;
-
Lange, J., Sharfman, W., Alani, R.M., and Balch C. Clinical Oncology (Abeloff, M.D., et. al). Malignant Melanoma. Elsevier Press. Philadelphia. 2008.
-
Ryu B, Kim DS, DeLuca AM, Healey MA, Dunlap S, Fackler MJ, Herman J, Alani RM. Id1 expression is transcriptionally regulated in radial growth phase melanomas. Int J Cancer. 2007 Oct 15; 121(8):1705-9.View Related Profiles. PMID: 17565736
-
Keefe MJ and Alani RM. Johns Hopkins Biotech 2007: Investing in Cancer Research. Global Assessment of Tumor-Endothelial Cell Communication Identifies Neuropilin-2 as a Mediator of Melanoma Growth. 2007.
-
Alani RM, Young AZ, Busam KJ. METHOD FOR EVALUATING A TISSUE OR BIOPSY SAMPLE TO DETERMINE IF THE SAMPLE IS EARLY-STAGE MELANOMA. 2007.
-
-
Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol. 2007 Apr 20; 25(12):1606-20. PMID: 17443002
-
Ryu B, Kim DS, DeLuca AM, Alani RM. AACR. Comprehensive gene expression profiling identifies molecular signatures associated with malignant melanoma. 2007.
-
DeLuca AM, Ryu B, Alani RM. Journal of Investigative Dermatology. Role of Nuclear Factor Kappa-B in Melanoma Progression. 2007; 127:S151.
-
Fecher, L., Cummings, S, Keefe, M., and R.M. Alani. Towards a Molecular Classification of Melanoma. Journal of Clinical Oncology. 2007; 25(12):1606-1620.
-
Silverthorn CF and Alani RM. Defining the role of hypoxia in melanoma development and response to therapy. Melanoma Research. 2006; 16:S105.
-
Cummings, S., Ryu, B., and Alani RM. Defining the role of Id1 in melanoma development and progression. Melanoma Research. 2006; 16:S77.
-
Zheng Y, Balasubramanyam K, Cebrat M, Buck D, Guidez F, Zelent A, Alani RM, Cole PA. Synthesis and evaluation of a potent and selective cell-permeable p300 histone acetyltransferase inhibitor. J Am Chem Soc. 2005 Dec 14; 127(49):17182-3. PMID: 16332055
-
Guidez F, Howell L, Isalan M, Cebrat M, Alani RM, Ivins S, Hormaeche I, McConnell MJ, Pierce S, Cole PA, Licht J, Zelent A. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol Cell Biol. 2005 Jul; 25(13):5552-66. PMID: 15964811; PMCID: PMC1156991; DOI: 10.1128/MCB.25.13.5552-5566.2005;
-
Govindarajan B, Shah A, Cohen C, Arnold RS, Schechner J, Chung J, Mercurio AM, Alani R, Ryu B, Fan CY, Cuezva JM, Martinez M, Arbiser JL. Malignant transformation of human cells by constitutive expression of platelet-derived growth factor-BB. J Biol Chem. 2005 Apr 8; 280(14):13936-43.View Related Profiles. PMID: 15695519
-
Alani RM, Silverthorn CF, Orosz K. Tumor angiogenesis in mice and men. Cancer Biol Ther. 2004 Jun; 3(6):498-500. PMID: 15153806
-
Dunlap S, Yu X, Cheng L, Civin CI, Alani RM. High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system. J Invest Dermatol. 2004 Feb; 122(2):549-51. PMID: 15009744
-
Lange, J., Sharfman, W., Alani, R.M., and Balch C. Clinical Oncology (Abeloff, M.D., et. al, eds.). Malignant Melanoma. Elsevier Press. Philadelphia. 2004.
-
Zheng Y, Thompson PR, Cebrat M, Wang L, Devlin MK, Alani RM, Cole PA. Selective HAT inhibitors as mechanistic tools for protein acetylation. Methods Enzymol. 2004; 376:188-99. PMID: 14975306
-
Sikder H, Huso DL, Zhang H, Wang B, Ryu B, Hwang ST, Powell JD, Alani RM. Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell. 2003 Oct; 4(4):291-9.View Related Profiles. PMID: 14585356
-
Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell. 2003 Jun; 3(6):525-30.View Related Profiles. PMID: 12842081
-
Volpert OV, Alani RM. Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. Cancer Cell. 2003 Mar; 3(3):199-200. PMID: 12676576
-
Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K, Alani RM. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell. 2002 Dec; 2(6):473-83. PMID: 12498716
-
Alani RM, Busam K. Acupuncture granulomas. J Am Acad Dermatol. 2001 Dec; 45(6 Suppl):S225-6. PMID: 11712067
-
Polsky D, Young AZ, Busam KJ, Alani RM. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res. 2001 Aug 15; 61(16):6008-11. PMID: 11507043
-
Alani RM, Young AZ, Shifflett CB. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci U S A. 2001 Jul 3; 98(14):7812-6. PMID: 11427735; PMCID: PMC35424
-
Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Münger K. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci U S A. 1999 Aug 17; 96(17):9637-41. PMID: 10449746; PMCID: PMC22262
-
Alani RM, Hasskarl J, Münger K. Alterations in cyclin-dependent kinase 2 function during differentiation of primary human keratinocytes. Mol Carcinog. 1998 Dec; 23(4):226-33. PMID: 9869451
-
Alani, R.M., and Munger K. Science and Medicine. Human Papillomaviruses. 1998; 5(3):28-35.
-
Alani RM, Münger K. Human papillomaviruses and associated malignancies. J Clin Oncol. 1998 Jan; 16(1):330-7. PMID: 9440761
-
Jones DL, Alani RM, Münger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 1997 Aug 15; 11(16):2101-11. PMID: 9284049; PMCID: PMC316455
-
Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K, Libermann TA. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol. 1997 Aug; 17(8):4419-33. PMID: 9234700; PMCID: PMC232296
-
Arbiser JL, Alani R, Flynn E, Wooten V, Byers HR. Effects of thallium ion on cellular components of the skin. J Dermatol. 1997 Mar; 24(3):147-55. PMID: 9114610
-
Alani, R.M., and Dover, J.S. Cutaneous Medicine and Surgery Self Assessment and Review (Dover J.S., et al). Inflammation, Pruritus, Percutaneous Absorption, and Topical Therapy. WB Saunders Co. Philadelphia. 1996.
-
Brown PH, Alani R, Preis LH, Szabo E, Birrer MJ. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene. 1993 Apr; 8(4):877-86. PMID: 8455942
-
Oxman, M.N., and Alani, R. Dermatology in General Medicine (Fitzpatrick, T.B., et al). Varicella and Herpes Zoster. McGraw-Hill. New York. 1993.
-
Birrer MJ, Alani R, Cuttitta F, Preis LH, Sabich AL, Sanders DA, Siegfried JM, Szabo E, Brown PH. Early events in the neoplastic transformation of respiratory epithelium. J Natl Cancer Inst Monogr. 1992; (13):31-7. PMID: 1389694
-
Alani R, Brown P, Binétruy B, Dosaka H, Rosenberg RK, Angel P, Karin M, Birrer MJ. The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells. Mol Cell Biol. 1991 Dec; 11(12):6286-95. PMID: 1944289; PMCID: PMC361817
-
Brown, P.H., Sanders. D.A., Alani, R., Birrer, M.J. Proc Annu Meet Am Assoc Cancer Res. Dominant-negative mutants of c-jun prevent Jun-induced transformation. 1991; 32:A1762.
-
Alani. R.M., Schutte, J., Minna. J.D., Birrer, M.J. Abstracts from the Fifth Annual Meeting on Oncogenes. Regions in Human c-jun-A Important for Transformation. 1989; 439.
-
Konkle BA, Kim S, Iannuzzi MC, Alani R, Collins FS, Ginsburg D. SacI RFLP in the human von Willebrand factor gene. Nucleic Acids Res. 1987 Aug 25; 15(16):6766. PMID: 2888092; PMCID: PMC306166
-
Matias, J.R., Alani, R., Orentreich, N. Measurement of the rate of hair growth using a fluorescent tracer technique. J. Soc. Cosmet. Chem. 1987; 38:77-82.
-
Malloy, V., Alani, R., Matias, J.R., Orentreich, N. The Sexual Dimorphism in the Ear Sebaceous Glands of Rabbits and Rodents; Regional Variation and Species Differences. Clinical Research. 1984; 32(2):600.